SPONSOR
Nationwide Children's Hospital
Total Trials
3
Recruiting
3
Phases
Phase 2
Conditions studied: NeuroblastomaSarcomaHematopoietic Stem Cell TransplantationHematologic MalignancyGERD in Infants
Nationwide Children's Hospital is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Neuroblastoma, Sarcoma, Hematopoietic Stem Cell Transplantation, Hematologic Malignancy.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Nationwide Children's Hospital
How many clinical trials has Nationwide Children's Hospital sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Nationwide Children's Hospital, of which 3 are actively recruiting participants. These trials cover conditions including Neuroblastoma, Sarcoma, Hematopoietic Stem Cell Transplantation. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Nationwide Children's Hospital research focus on?
Nationwide Children's Hospital clinical trials span Neuroblastoma, Sarcoma, Hematopoietic Stem Cell Transplantation, Hematologic Malignancy, GERD in Infants. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Nationwide Children's Hospital clinical trial?
To participate in a Nationwide Children's Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Nationwide Children's Hospital trials with current recruitment status updated daily.
Clinical Trials by Nationwide Children's Hospital
NCT05135975 Phase 2
Recruiting
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
Neuroblastoma
NCT06082947
Recruiting
αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT)
Hematopoietic Stem Cell Transplantation
NCT06114836
Recruiting
GERD Infant Feeding Therapeutics Trial (GIFT Trial)
GERD in Infants
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology